# LNG-IUS for Treatment of Dysmenorrhea

> **NCT01601366** · PHASE2 · COMPLETED · sponsor: **Omar Mamdouh Shaaban** · enrollment: 62 (actual)

## Conditions studied

- Adenomyosis

## Interventions

- **DEVICE:** LNG-IUS
- **DRUG:** Combined oral contraceptives

## Key facts

- **NCT ID:** NCT01601366
- **Lead sponsor:** Omar Mamdouh Shaaban
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-04
- **Final completion:** 2015-04
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601366, "LNG-IUS for Treatment of Dysmenorrhea". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01601366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*